Search
Returning search results with filters:
Remove filter for
Issue: COVID
Remove filter for
Last updated: 2021
Clear all
Type
Category
Issue
Last updated
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 1 of 1 items.
Bamlanivimab - Potential Risk of Treatment Failure Due to Circulation of Resistant SARS-CoV-2 Variants
… Key messages A potential risk of treatment failure of bamlanivimab against certain severe acute respiratory … variants was identified through global surveillance. Bamlanivimab is expected to retain neutralizing activity … variant. Healthcare professionals are advised that: Bamlanivimab, in in vitro assays, exhibited reduced activity …
AlertHealth professional risk communication | 2021-04-28